These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

763 related articles for article (PubMed ID: 18158124)

  • 1. Human leukocyte antigen-G expression after kidney transplantation is associated with a reduced incidence of rejection.
    Crispim JC; Duarte RA; Soares CP; Costa R; Silva JS; Mendes-Júnior CT; Wastowski IJ; Faggioni LP; Saber LT; Donadi EA
    Transpl Immunol; 2008 Feb; 18(4):361-7. PubMed ID: 18158124
    [TBL] [Abstract][Full Text] [Related]  

  • 2. Frequency of insertion/deletion polymorphism in exon 8 of HLA-G and kidney allograft outcome.
    Crispim JC; Mendes-Junior CT; Wastowski IJ; Costa R; Castelli EC; Saber LT; Donadi EA
    Tissue Antigens; 2008 Jan; 71(1):35-41. PubMed ID: 17971051
    [TBL] [Abstract][Full Text] [Related]  

  • 3. Myocardial HLA-G reliably indicates a low risk of acute cellular rejection in heart transplant recipients.
    Sheshgiri R; Rouas-Freiss N; Rao V; Butany J; Ramzy D; Krawice-Radanne I; Ross HJ; Carosella ED; Delgado DH
    J Heart Lung Transplant; 2008 May; 27(5):522-7. PubMed ID: 18442718
    [TBL] [Abstract][Full Text] [Related]  

  • 4. A study of HLA-G polymorphism and linkage disequilibrium in renal transplant patients and their donors.
    Pirri A; Contieri FC; Benvenutti R; Bicalho Mda G
    Transpl Immunol; 2009 Jan; 20(3):143-9. PubMed ID: 18926911
    [TBL] [Abstract][Full Text] [Related]  

  • 5. Soluble total human leukocyte antigen class I and human leukocyte antigen-G molecules in kidney and kidney/pancreas transplantation.
    Rebmann V; Bartsch D; Wunsch A; Möllenbeck P; Golda T; Viebahn R; Grosse-Wilde H
    Hum Immunol; 2009 Dec; 70(12):995-9. PubMed ID: 19651178
    [TBL] [Abstract][Full Text] [Related]  

  • 6. Post transplant development of MICA and anti-HLA antibodies is associated with acute rejection episodes and renal allograft loss.
    Panigrahi A; Gupta N; Siddiqui JA; Margoob A; Bhowmik D; Guleria S; Mehra NK
    Hum Immunol; 2007 May; 68(5):362-7. PubMed ID: 17462503
    [TBL] [Abstract][Full Text] [Related]  

  • 7. Expression of HLA-G and MICA mRNA in renal allograft.
    Racca AL; Veaute CM; Bailat AS; Gaite L; Arriola M; Hajos SE; Malan Borel IS
    Transpl Immunol; 2009 May; 21(1):10-2. PubMed ID: 19193353
    [TBL] [Abstract][Full Text] [Related]  

  • 8. Impact of human leukocyte antigen matching and recipients' panel reactive antibodies on two-year outcome in presensitized renal allograft recipients.
    Meng HL; Jin XB; Li XT; Wang HW; Lü JJ
    Chin Med J (Engl); 2009 Feb; 122(4):420-6. PubMed ID: 19302748
    [TBL] [Abstract][Full Text] [Related]  

  • 9. Anti-human leukocyte antigen and donor-specific antibodies detected by luminex posttransplant serve as biomarkers for chronic rejection of renal allografts.
    Lachmann N; Terasaki PI; Budde K; Liefeldt L; Kahl A; Reinke P; Pratschke J; Rudolph B; Schmidt D; Salama A; Schönemann C
    Transplantation; 2009 May; 87(10):1505-13. PubMed ID: 19461487
    [TBL] [Abstract][Full Text] [Related]  

  • 10. Clinical and anti-HLA antibody profile of nine renal transplant recipients with failed grafts: donor-specific and non-donor-specific antibody development.
    Rebellato LM; Ozawa M; Verbanac KM; Catrou P; Haisch CE; Terasaki PI
    Clin Transpl; 2006; ():241-53. PubMed ID: 18365382
    [TBL] [Abstract][Full Text] [Related]  

  • 11. [Expression of human leucocyte antigen G in peripheral blood of kidney transplantation recipients].
    Xiao L; Shi BY; Cai M; He XY; Xu XG; Han Y; Zhou WQ; Meng XY; Gao Y
    Zhonghua Yi Xue Za Zhi; 2010 Jan; 90(4):241-4. PubMed ID: 20356537
    [TBL] [Abstract][Full Text] [Related]  

  • 12. The 14-bp deletion in the HLA-G gene indicates a low risk for acute cellular rejection in heart transplant recipients.
    Twito T; Joseph J; Mociornita A; Rao V; Ross H; Delgado DH
    J Heart Lung Transplant; 2011 Jul; 30(7):778-82. PubMed ID: 21482149
    [TBL] [Abstract][Full Text] [Related]  

  • 13. Monitoring anti-HLA Class I IgG antibodies in renal transplant recipients.
    Aragão E; Moura LA; Pacheco-Silva A
    Transplant Proc; 2004 May; 36(4):836-7. PubMed ID: 15194287
    [TBL] [Abstract][Full Text] [Related]  

  • 14. Comparison of renal allograft outcomes in combined liver-kidney transplantation versus subsequent kidney transplantation in liver transplant recipients: Analysis of UNOS Database.
    Simpson N; Cho YW; Cicciarelli JC; Selby RR; Fong TL
    Transplantation; 2006 Nov; 82(10):1298-303. PubMed ID: 17130778
    [TBL] [Abstract][Full Text] [Related]  

  • 15. Soluble CD30 and HLA antibodies as potential risk factors for kidney transplant rejection.
    Slavcev A; Lácha J; Honsová E; Sajdlová H; Lodererová A; Vitko S; Skibová J; Striz I
    Transpl Immunol; 2005 Jun; 14(2):117-21. PubMed ID: 15935302
    [TBL] [Abstract][Full Text] [Related]  

  • 16. Donor-specific antibodies against HLA, MICA, and GSTT1 in patients with allograft rejection and C4d deposition in renal biopsies.
    Alvarez-Márquez A; Aguilera I; Gentil MA; Caro JL; Bernal G; Fernández Alonso J; Acevedo MJ; Cabello V; Wichmann I; Gonzalez-Escribano MF; Núñez-Roldán A
    Transplantation; 2009 Jan; 87(1):94-9. PubMed ID: 19136897
    [TBL] [Abstract][Full Text] [Related]  

  • 17. Human leukocyte antigen-G 3' untranslated region polymorphisms are associated with better kidney allograft acceptance.
    Cilião Alves DC; de Oliveira Crispim JC; Castelli EC; Mendes-Junior CT; Deghaide NH; Barros Silva GE; Costa RS; Saber LT; Moreau P; Donadi EA
    Hum Immunol; 2012 Jan; 73(1):52-9. PubMed ID: 22044721
    [TBL] [Abstract][Full Text] [Related]  

  • 18. Incidence and prediction of early antibody-mediated rejection due to non-human leukocyte antigen-antibodies.
    Amico P; Hönger G; Bielmann D; Lutz D; Garzoni D; Steiger J; Mihatsch MJ; Dragun D; Schaub S
    Transplantation; 2008 Jun; 85(11):1557-63. PubMed ID: 18551059
    [TBL] [Abstract][Full Text] [Related]  

  • 19. 14-Base pair polymorphism of human leukocyte antigen-G as genetic determinant in heart transplantation and cyclosporine therapy monitoring.
    Torres MI; Luque J; Lorite P; Isla-Tejera B; Palomeque T; Aumente MD; Arizon J; Peña J
    Hum Immunol; 2009 Oct; 70(10):830-5. PubMed ID: 19638290
    [TBL] [Abstract][Full Text] [Related]  

  • 20. Immunoglobulin M-to-immunoglobulin G anti-human leukocyte antigen class II antibody switching in cardiac transplant recipients is associated with an increased risk of cellular rejection and coronary artery disease.
    Lietz K; John R; Burke E; Schuster M; Rogers TB; Suciu-Foca N; Mancini D; Itescu S
    Circulation; 2005 Oct; 112(16):2468-76. PubMed ID: 16230499
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 39.